Clinical Trials Browser

Observational × Rivaroxaban × Classical hematology × Clear all

Embolism, Neoplasms, Venous Thromboembolism

NCT04979780 2024-10-31

OSCAR-US

Completed

3,708 enrolled

Classical hematology

Treatment of Venous Thromboembolism in Cancer Patients

NCT06284343 2024-09-19

GynCAT

Recruiting

1,800 enrolled

Classical hematologyGynecologic

Uterine Cervical Neoplasms, Neoplasms, Ovarian Neoplasms, Thrombosis, Vaginal Neoplasms, Endometrial Neoplasms, Venous Thromboembolism

NCT05150938 2023-12-18

A Study to Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)

Completed

5,737 enrolled

Classical hematology

Treatment of Venous Thromboembolism in Cancer Patients

NCT05112666 2023-04-03

A Study to Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK)

Completed

2,601 enrolled

Classical hematology

Treatment of Venous Thromboembolism in Cancer Patients

NCT05461807 2022-10-26

H2H-OSCAR-US

Completed

2,437 enrolled

Classical hematology

Neoplasms, Venous Thromboembolism

NCT03965741 2021-11-30

PRACTISE

Completed

97,765 enrolled

Classical hematology

Venous Thromboembolism

NCT03214172 2018-09-06

Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban

Completed

1,000 enrolled

Classical hematology

Venous Thromboembolism

Clinical Trials

VICTORIE

OSCAR-US

GynCAT

A Study to Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)

A Study to Gather Information About Rivaroxaban in Patients in the United Kingdom Who Have Cancer and Thrombosis (OSCAR-UK)

H2H-OSCAR-US

PRACTISE

Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban